Patterns and trends in cancer screening in the United States

Preventing Chronic Disease

Volumn 15, Issue 7, 2018, Pages

  Hall, Ingrid J ^a   Tangka, Florence K L ^a   Sabatino, Susan A ^a   Thompson, Trevor D ^a   Graubard, Barry I ^b   Breen, Nancy ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CROSS-SECTIONAL STUDY; EARLY CANCER DIAGNOSIS; FEMALE; HEALTH SURVEY; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM; PROCEDURES; SEX RATIO; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES; YOUNG ADULT;

ADULT; AGED; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85051086870     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: 10.5888/pcd15.170465     Document Type: Article

References (30)

1. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2014. Atlanta (GA): US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2017. www.cdc.gov/ uscs. Accessed September 25, 2017
2. Healthy People 2020. Washington (DC): US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. https://www.healthypeople.gov/2020/ topics-objectives/topic/cancer/objectives. Accessed September 25, 2017
3. Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157(2):120-34
4. Hutchinson R, Akhtar A, Haridas J, Bhat D, Roehrborn C, Lotan Y. Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening. Cancer 2016; 122(24):3785-93
5. National Center for Health Statistics. NHIS data, questionnaires and related documentation. https:// www.cdc.gov/nchs/nhis/data-questionnaires documentation.htm. Accessed September 25, 2017
6. Korn EL, Graubard BI. Analysis of Health Surveys. New York (NY): John Wiley and Sons, Inc; 1999
7. Sabatino SA, White MC, Thompson TD, Klabunde CN; Centers for Disease Control and Prevention (CDC). Cancer screening test use-United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64(17):464-8
8. Brown ML, Klabunde CN, Cronin KA, White MC, Richardson LC, McNeel TS. Challenges in meeting Healthy People 2020 objectives for cancer-related preventive services, National Health Interview Survey, 2008 and 2010. Prev Chronic Dis 2014;11:E29
9. Sauer AG, Siegel RL, Jemal A, Fedewa SA. Updated review of prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol Biomarkers Prev 2017;26(8):1192-208; Epub ahead of print
10. National Cancer Institute. Cancer Trends Progress Report. National Cancer Institute, NIH, DHHS, Bethesda, (MD): National Cancer Institute; January 2017, https:// progressreport.cancer.gov. Accessed September 25, 2017
11. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 2011; 33(1):101-10
12. Watson M, Benard V, King J, Crawford A, Saraiya M. National assessment of HPV and Pap tests: changes in cervical cancer screening, National Health Interview Survey. Prev Med 2017;100:243-7
13. Drazer MW, Huo D, Eggener SE. National prostate cancer screening rates after the 2012 US Preventive Services Task Force recommendation discouraging Prostate-Specific Antigen-based screening. J Clin Oncol 2015;33(22):2416-23
14. Shoag J, Halpern JA, Lee DJ, Mittal S, Ballman KV, Barbieri CE, et al. Decline in prostate cancer screening by primary care physicians: an analysis of trends in the use of digital rectal examination and prostate specific antigen testing. J Urol 2016; 196(4):1047-52
15. Grossman DCUS, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, et al. Preventive Services Task Force. Screening for Prostate Cancer. US Preventive Services Task Force Recommendation Statement. JAMA 2018; 319(18):1901-13
16. Fedewa SA, Ma J, Sauer AG, Siegel RL, Smith RA, Wender RC, et al. How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018? Cancer 2015;121(23):4258-65
17. Ramdass P, Petraro P, Via C, Shahrokni A, Nawaz H. Providers role in colonoscopy screening for colorectal cancer. Am J Health Behav 2014;38(2):234-44
18. May FP, Almario CV, Ponce N, Spiegel BM. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening. Am J Gastroenterol 2015;110(10):1388-94
19. Miranda-Diaz C, Betancourt E, Ruiz-Candelaria Y, HunterMellado RF. Barriers for compliance to breast, colorectal, and cervical screening cancer tests among Hispanic patients. Int J Environ Res Public Health 2015;13(1):ijerph13010021
20. Costas-Muñiz R, Jandorf L, Philip E, Cohen N, Villagra C, Sriphanlop P, et al. Examining the impact of Latino nativity, migration, and acculturation factors on colonoscopy screening. J Community Health 2016;41(5):903-9
21. Nápoles AM, Santoyo-Olsson J, Stewart AL, Olmstead J, Gregorich SE, Farren G, et al. Physician counseling on colorectal cancer screening and receipt of screening among Latino patients. J Gen Intern Med 2015;30(4):483-9
22. Chawla N, Breen N, Liu B, Lee R, Kagawa-Singer M. Asian American women in California: a pooled analysis of predictors for breast and cervical cancer screening. Am J Public Health 2015;105(2):e98-109
23. Thompson CA, Gomez SL, Chan A, Chan JK, McClellan SR, Chung S, et al. Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans. Cancer Epidemiol Biomarkers Prev 2014; 23(11):2208-17
24. The Community Guide. Cancer. https:// www.thecommunityguide.org/topic/cancer. Accessed February 25, 2018
25. Joseph DA, Redwood D, DeGroff A, Butler EL. Use of evidence-based interventions to address disparities in colorectal cancer screening. MMWR Suppl 2016;65(1):21-8
26. Agency for Healthcare Research and Quality. Care Coordination. https://www.ahrq.gov/professionals/preventionchronic-care/improve/coordination/index.html. Accessed February 20, 2018
27. The Community Guide. Cancer screening: multicomponent interventions-breast cancer. https:// www.thecommunityguide.org/findings/cancer-screeningmulticomponent-interventions-breast-cancer. Accessed February 26, 2018
28. Hall IJ, Johnson-Turbes A, Berkowitz Z, Zavahir Y. The African American Women and Mass Media (AAMM) campaign in Georgia: quantifying community response to a CDC pilot campaign. Cancer Causes Control 2015; 26(5):787-94
29. Byrd TL, Wilson KM, Smith JL, Coronado G, Vernon SW, Fernandez-Esquer ME, et al. AMIGAS: a multicity, multicomponent cervical cancer prevention trial among Mexican American women. Cancer 2013;119(7):1365-72
30. Nguyen TT, Tsoh JY, Woo K, Stewart SL, Le GM, Burke A, et al. Colorectal cancer screening and Chinese Americans: efficacy of lay health worker outreach and print materials. Am J Prev Med 2017;52(3):e67-76